Penbutolol

Penbutolol has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 26, 2021: “Identification and drug-induced reversion of molecular signatures of Alzheimer's disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse models”.

Intervention

1 paper studies it1 findingUpdated

PubChemChEBI

See all 1 papers on penbutolol

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya and 7 more
  • Animals1

What did studies of penbutolol find?

1

Studies of penbutolol measured one outcome, cognitive impairment.

Cognitive impairment

downin mice1

1 study
  1. Penbutolol decreases cognitive impairment in AD mice.

    “two NSAIDs (dexketoprofen and etodolac) and two anti-hypertensives (penbutolol and bendroflumethiazide) that overturn the cognitive impairment in AD mice”

    Animalsin AD micehippocampus

    Identification and drug-induced reversion of molecular signatures of Alzheimer's disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse models

    Genome medicine

Latest